BeOne Medicines Ltd
199 hedge funds and large institutions have $6.8B invested in BeOne Medicines Ltd in 2019 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 70 increasing their positions, 56 reducing their positions, and 25 closing their positions.
28% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 25
25% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 56
4% more funds holding
Funds holding: 192 → 199 (+7)
2% more capital invested
Capital invested by funds: $6.65B → $6.8B (+$146M)
0.15% more ownership
Funds ownership: 6.18% → 6.33% (+0.15%)
17% less call options, than puts
Call options by funds: $9.84M | Put options by funds: $11.8M
36% less funds holding in top 10
Funds holding in top 10: 14 → 9 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$110M |
| 2 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
+$50.5M |
| 3 |
VanEck Associates
New York
|
+$17.1M |
| 4 |
CII
Capital International Inc
Los Angeles,
California
|
+$15.8M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$23.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.9M |
| 3 |
ICP
Indus Capital Partners
New York
|
-$19.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$16.7M |
| 5 |
Morgan Stanley
New York
|
-$16.5M |
ONC Hedge Fund Activity: Q1 2019 in Review
199 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2019, worth a combined $6.8B — up 2.2% from $6.65B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new ONC positions and 25 closed out — a net gain of 7 holders — while 70 added to existing stakes and 56 trimmed.
The largest buyer was Capital International Investors, adding an estimated $110M. The largest seller was Myriad Asset Management, exiting entirely with an estimated $23.3M sold.
- 199 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2019, up from 192 in Q4 2018.
- Funds reported $6.8B of BeOne Medicines Ltd stock for Q1 2019, up 2.2% quarter-over-quarter.
- 32 funds opened new BeOne Medicines Ltd positions in Q1 2019 and 25 closed out, a net change of +7 holders.
- The largest BeOne Medicines Ltd buyer in Q1 2019 was Capital International Investors, an estimated $110M added.
- The largest BeOne Medicines Ltd seller in Q1 2019 was Myriad Asset Management, an estimated $23.3M sold.
Based on aggregated 13F filings for Q1 2019.